AU6568300A - Novel compounds - Google Patents

Novel compounds

Info

Publication number
AU6568300A
AU6568300A AU65683/00A AU6568300A AU6568300A AU 6568300 A AU6568300 A AU 6568300A AU 65683/00 A AU65683/00 A AU 65683/00A AU 6568300 A AU6568300 A AU 6568300A AU 6568300 A AU6568300 A AU 6568300A
Authority
AU
Australia
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65683/00A
Inventor
Joelle Thonnard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9918034.1A external-priority patent/GB9918034D0/en
Priority claimed from GBGB9918036.6A external-priority patent/GB9918036D0/en
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Publication of AU6568300A publication Critical patent/AU6568300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU65683/00A 1999-07-30 2000-07-31 Novel compounds Abandoned AU6568300A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9918034.1A GB9918034D0 (en) 1999-07-30 1999-07-30 Novel compounds
GB9918036 1999-07-30
GBGB9918036.6A GB9918036D0 (en) 1999-07-30 1999-07-30 Novel compounds
GB9918034 1999-07-30
PCT/EP2000/007365 WO2001009337A2 (en) 1999-07-30 2000-07-31 Moraxella catarrhalis antigens basb122 and basb124

Publications (1)

Publication Number Publication Date
AU6568300A true AU6568300A (en) 2001-02-19

Family

ID=26315813

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65683/00A Abandoned AU6568300A (en) 1999-07-30 2000-07-31 Novel compounds

Country Status (4)

Country Link
EP (1) EP1204749A2 (en)
AU (1) AU6568300A (en)
CA (1) CA2378168A1 (en)
WO (1) WO2001009337A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090576A (en) * 1996-03-08 2000-07-18 Connaught Laboratories Limited DNA encoding a transferrin receptor of Moraxella
CA2378687A1 (en) * 1999-06-18 2000-12-28 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome

Also Published As

Publication number Publication date
CA2378168A1 (en) 2001-02-08
WO2001009337A2 (en) 2001-02-08
EP1204749A2 (en) 2002-05-15
WO2001009337A3 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
AU1278701A (en) Novel compounds
AU5546000A (en) Compounds
AU2001271434A1 (en) Novel skateboard-bicycle combination
AU4260199A (en) Novel compounds
AU2408300A (en) Novel compounds
AUPP999799A0 (en) New compound
AU2014800A (en) Novel compounds
AU1746401A (en) Compounds
AUPQ441499A0 (en) Novel compound
AU6032100A (en) New compounds
AU3997700A (en) Anti-first-pass effect compounds
AU4132200A (en) Novel compounds
AU2359301A (en) Novel ss-defensins
AU2109700A (en) Novel compounds
AU2187799A (en) Novel taxaneterpine compounds
AU5787901A (en) Compound
AU6567400A (en) Substituted 2-imino-thiazolines
AU2288900A (en) Novel compounds
AU5119400A (en) Compounds
AU1385701A (en) Novel compounds
AU7784700A (en) Novel compounds
AU4156800A (en) Novel compounds
AU6168900A (en) Compounds
AU2668000A (en) Bis-styrylbiphenyl compounds
AU2985200A (en) Novel sialoadhesins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase